慢性阿片类药物使用独立增加初次全关节置换术后并发症和资源利用
该研究利用大型国家数据库纳入2016年1月至2019年12月因骨关节炎行择期单侧初次全髋或全膝关节置换的3,545,565例患者,比较慢性阿片类药物使用(OD)与无OD患者的院内术后并发症、住院时间和总费用,发现OD患者并发症风险更高、总费用和住院时间更高、出院至康复机构比例更高。
要点
- 慢性阿片类药物使用(OD)患者行全髋或全膝关节置换术后呼吸、胃肠、尿路感染、输血和深静脉血栓风险均更高。
- OD患者总费用为16,619±9,251美元 vs 15,603±9,181美元(P<.001),住院时间为2.15±1.37天 vs 2.03±1.23天(P<.001)。
- OD患者出院至康复机构的可能性为17.8% vs 15.7%(P<.001)。
核心结论
- 慢性阿片类药物使用与初次全髋和全膝关节置换术后院内并发症和费用更高相关。
- 需要进一步研究寻找减轻阿片类药物使用对并发症影响的策略。
研究设计与样本
- 利用大型国家数据库识别2016年1月至2019年12月因骨关节炎行择期、单侧、初次全髋和全膝关节置换的患者共3,545,565例。
- 比较慢性阿片类药物使用阳性患者与无慢性阿片类药物使用患者的院内术后并发症、住院时间和通货膨胀调整后总费用。
- 采用逻辑回归分析控制混杂因素。
主要发现
- 慢性阿片类药物使用患者行全髋关节置换术后呼吸系统并发症OR为1.4,行全膝关节置换术后OR为1.3。
- 慢性阿片类药物使用患者行全髋关节置换术后胃肠并发症OR为1.8,行全膝关节置换术后OR为1.8。
- 慢性阿片类药物使用患者行全髋关节置换术后尿路感染OR为1.1,行全膝关节置换术后OR为1.2。
- 慢性阿片类药物使用患者行全髋关节置换术后输血OR为1.5,行全膝关节置换术后OR为1.4;深静脉血栓OR分别为1.7和1.6。
- 慢性阿片类药物使用患者总费用为16,619±9,251美元 vs 15,603±9,181美元(P<.001),住院时间为2.15±1.37天 vs 2.03±1.23天(P<.001),出院至康复机构可能性为17.8% vs 15.7%(P<.001)。
局限性
- 需要进一步研究寻找减轻阿片类药物使用对并发症影响的策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Current literature suggests a link between the chronic use of opioids and musculoskeletal surgical complications. Given the current opioid epidemic, the need to elucidate the effects of chronic opioid use (OD) on patient outcomes and cost has become important. The purpose of this study was to determine if OD is an independent risk factor for inpatient postoperative complications and resource utilization after primary total joint arthroplasty. METHODS: A total of 3,545,565 patients undergoing elective, unilateral, primary total hip (THA) and knee (TKA) arthroplasty for osteoarthritis from January 2016 to December 2019 were identified using a large national database. In-hospital postoperative complications, length of stay, and total costs adjusted for inflation in opioid + patients were compared with patients without chronic opioid use (OD). Logistic regression analyses were used to control for cofounding factors. RESULTS: OD patients undergoing either THA or TKA had a higher risk of postoperative complications including respiratory (odds ratio (OR): 1.4 and OR: 1.3), gastrointestinal (OR: 1.8 and OR: 1.8), urinary tract infection (OR: 1.1 and OR: 1.2), blood transfusion (OR: 1.5 and OR: 1.4), and deep vein thrombosis (OR: 1.7 and OR: 1.6), respectively. Total cost ($16,619 ± $9,251 versus $15,603 ± $9,181, P < .001), lengths of stay (2.15 ± 1.37 versus 2.03 ± 1.23, P < .001), and the likelihood for discharge to a rehabilitation facility (17.8 versus 15.7%, P < .001) were higher in patients with OD. CONCLUSION: OD was associated with higher risk for in-hospital postoperative complications and cost after primary THA and TKA. Further studies to find strategies to mitigate the impact of opioid use on complications are required.
引用
- Pagan DN, Hernandez VH, Reddy GB, et al. Chronic Opioid Use Independently Increases Complications and Resource Utilization After Primary Total Joint Arthroplasty. J Arthroplasty. 2022. PMID: 36529200. doi:10.1016/j.arth.2022.12.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。